logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Konstantinou, Anastasis
    Born in July 1984
    Individual (3 offsprings)
    Officer
    icon of calendar 2014-06-24 ~ now
    OF - Director → CIF 0
  • 2
    Seelenfreund, Yigal
    Born in August 1967
    Individual (2 offsprings)
    Officer
    icon of calendar 2022-05-23 ~ now
    OF - Director → CIF 0
  • 3
    Ridsdale, Andrew John
    Born in March 1971
    Individual (2 offsprings)
    Officer
    icon of calendar 2022-05-23 ~ now
    OF - Director → CIF 0
  • 4
    DEXCEL-PHARMA LABORATORIES LIMITED
    icon of addressAshacres House, Draycott-in-the-clay, Ashbourne, England
    Active Corporate (4 parents, 1 offspring)
    Profit/Loss (Company account)
    -56,509 GBP2023-07-01 ~ 2024-06-30
    Person with significant control
    icon of calendar 2016-08-23 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
Ceased 9
  • 1
    Kappler, Michael Roy
    Company Director born in September 1948
    Individual (1 offspring)
    Officer
    icon of calendar 1996-10-31 ~ 2010-05-10
    OF - Director → CIF 0
    Kappler, Michael Roy
    Individual (1 offspring)
    Officer
    icon of calendar 1997-01-21 ~ 2010-05-10
    OF - Secretary → CIF 0
  • 2
    Moore, Debbie
    Individual
    Officer
    icon of calendar 1994-08-31 ~ 1994-08-31
    OF - Nominee Secretary → CIF 0
  • 3
    Oren, Dan
    Company Manager born in February 1941
    Individual
    Officer
    icon of calendar 1994-08-31 ~ 2022-05-23
    OF - Director → CIF 0
  • 4
    Millner, Harry
    Company Director born in February 1925
    Individual
    Officer
    icon of calendar 1996-10-31 ~ 2002-11-05
    OF - Director → CIF 0
  • 5
    Brown, Kevin Thomas
    Born in May 1958
    Individual (3 offsprings)
    Officer
    icon of calendar 1994-08-31 ~ 1994-08-31
    OF - Nominee Director → CIF 0
  • 6
    Avraham, Dov
    Vice President born in September 1968
    Individual
    Officer
    icon of calendar 2011-08-01 ~ 2014-06-24
    OF - Director → CIF 0
  • 7
    Carmeli, Liel
    Company Director born in September 1964
    Individual
    Officer
    icon of calendar 1996-10-31 ~ 2011-08-01
    OF - Director → CIF 0
  • 8
    Grigg, Terry
    Managing Director born in January 1949
    Individual (1 offspring)
    Officer
    icon of calendar 2006-05-16 ~ 2022-05-23
    OF - Director → CIF 0
    Grigg, Terry Kenneth
    Individual (1 offspring)
    Officer
    icon of calendar 2010-05-10 ~ 2022-05-23
    OF - Secretary → CIF 0
  • 9
    icon of addressC/o 8 Baker Street, London
    Active Corporate (2 parents, 19 offsprings)
    Equity (Company account)
    Retained earnings (accumulated losses)
    67,428 GBP2024-12-31
    Officer
    1994-08-31 ~ 1997-01-21
    PE - Secretary → CIF 0
parent relation
Company in focus

DEXCEL-PHARMA LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
222023-07-01 ~ 2024-06-30
212022-01-01 ~ 2023-06-30
Turnover/Revenue
21,547,541 GBP2023-07-01 ~ 2024-06-30
27,584,426 GBP2022-01-01 ~ 2023-06-30
Cost of Sales
-13,628,893 GBP2023-07-01 ~ 2024-06-30
-19,014,316 GBP2022-01-01 ~ 2023-06-30
Gross Profit/Loss
7,918,648 GBP2023-07-01 ~ 2024-06-30
8,570,110 GBP2022-01-01 ~ 2023-06-30
Distribution Costs
-1,765,013 GBP2023-07-01 ~ 2024-06-30
-1,981,725 GBP2022-01-01 ~ 2023-06-30
Administrative Expenses
-4,308,136 GBP2023-07-01 ~ 2024-06-30
-3,736,040 GBP2022-01-01 ~ 2023-06-30
Operating Profit/Loss
1,845,499 GBP2023-07-01 ~ 2024-06-30
2,852,345 GBP2022-01-01 ~ 2023-06-30
Other Interest Receivable/Similar Income (Finance Income)
91,362 GBP2023-07-01 ~ 2024-06-30
Profit/Loss on Ordinary Activities Before Tax
1,936,861 GBP2023-07-01 ~ 2024-06-30
2,852,345 GBP2022-01-01 ~ 2023-06-30
Profit/Loss
1,470,991 GBP2023-07-01 ~ 2024-06-30
2,331,070 GBP2022-01-01 ~ 2023-06-30
Intangible Assets
17,193,801 GBP2024-06-30
4,505,771 GBP2023-06-30
Property, Plant & Equipment
31,244 GBP2024-06-30
26,418 GBP2023-06-30
Fixed Assets
17,225,045 GBP2024-06-30
4,532,189 GBP2023-06-30
Total Inventories
8,274,264 GBP2024-06-30
8,286,461 GBP2023-06-30
Debtors
Current
7,014,904 GBP2024-06-30
4,591,978 GBP2023-06-30
Cash at bank and in hand
2,393,049 GBP2024-06-30
3,196,746 GBP2023-06-30
Current Assets
17,682,217 GBP2024-06-30
16,075,185 GBP2023-06-30
Creditors
Current, Amounts falling due within one year
-6,161,982 GBP2024-06-30
Net Current Assets/Liabilities
11,520,235 GBP2024-06-30
9,628,739 GBP2023-06-30
Total Assets Less Current Liabilities
28,745,280 GBP2024-06-30
14,160,928 GBP2023-06-30
Creditors
Non-current, Amounts falling due after one year
-6,751,061 GBP2024-06-30
Net Assets/Liabilities
21,880,858 GBP2024-06-30
14,160,928 GBP2023-06-30
Equity
Called up share capital
2 GBP2024-06-30
2 GBP2023-06-30
2 GBP2022-01-01
Other miscellaneous reserve
26,248,939 GBP2024-06-30
20,000,000 GBP2023-06-30
20,000,000 GBP2022-01-01
Retained earnings (accumulated losses)
-4,368,083 GBP2024-06-30
-5,839,074 GBP2023-06-30
-8,170,144 GBP2022-01-01
Equity
21,880,858 GBP2024-06-30
14,160,928 GBP2023-06-30
11,829,858 GBP2022-01-01
Profit/Loss
Retained earnings (accumulated losses)
1,470,991 GBP2023-07-01 ~ 2024-06-30
2,331,070 GBP2022-01-01 ~ 2023-06-30
Audit Fees/Expenses
25,000 GBP2023-07-01 ~ 2024-06-30
35,000 GBP2022-01-01 ~ 2023-06-30
Wages/Salaries
1,428,011 GBP2023-07-01 ~ 2024-06-30
1,822,983 GBP2022-01-01 ~ 2023-06-30
Social Security Costs
146,485 GBP2023-07-01 ~ 2024-06-30
190,013 GBP2022-01-01 ~ 2023-06-30
Staff Costs/Employee Benefits Expense
1,647,551 GBP2023-07-01 ~ 2024-06-30
2,111,448 GBP2022-01-01 ~ 2023-06-30
Director Remuneration
200,811 GBP2023-07-01 ~ 2024-06-30
173,834 GBP2022-01-01 ~ 2023-06-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
113,361 GBP2023-07-01 ~ 2024-06-30
Tax Expense/Credit at Applicable Tax Rate
484,215 GBP2023-07-01 ~ 2024-06-30
713,086 GBP2022-01-01 ~ 2023-06-30
Intangible Assets - Gross Cost
Development expenditure
98,917 GBP2023-06-30
Intangible Assets - Gross Cost
20,102,557 GBP2024-06-30
6,110,117 GBP2023-06-30
Intangible Assets - Accumulated Amortisation & Impairment
2,908,756 GBP2024-06-30
1,604,346 GBP2023-06-30
Intangible Assets - Increase From Amortisation Charge for Year
1,304,410 GBP2023-07-01 ~ 2024-06-30
Intangible Assets
Development expenditure
98,917 GBP2023-06-30
Property, Plant & Equipment - Gross Cost
Furniture and fittings
124,363 GBP2024-06-30
113,058 GBP2023-06-30
Computers
184,735 GBP2024-06-30
176,182 GBP2023-06-30
Property, Plant & Equipment - Gross Cost
309,098 GBP2024-06-30
289,240 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Furniture and fittings
109,263 GBP2023-06-30
Computers
153,559 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
262,822 GBP2023-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings, Owned/Freehold
1,844 GBP2023-07-01 ~ 2024-06-30
Owned/Freehold
15,032 GBP2023-07-01 ~ 2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
111,107 GBP2024-06-30
Computers
166,747 GBP2024-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
277,854 GBP2024-06-30
Property, Plant & Equipment
Furniture and fittings
13,256 GBP2024-06-30
3,795 GBP2023-06-30
Computers
17,988 GBP2024-06-30
22,623 GBP2023-06-30
Raw materials and consumables
8,274,264 GBP2024-06-30
8,286,461 GBP2023-06-30
Trade Debtors/Trade Receivables
Current
5,929,755 GBP2024-06-30
4,153,129 GBP2023-06-30
Amounts Owed by Group Undertakings
Current
217,435 GBP2024-06-30
161,408 GBP2023-06-30
Other Debtors
Current
456,233 GBP2024-06-30
Prepayments/Accrued Income
Current
411,481 GBP2024-06-30
277,441 GBP2023-06-30
Trade Creditors/Trade Payables
Current
975,378 GBP2024-06-30
708,440 GBP2023-06-30
Amounts owed to group undertakings
Current
3,541,595 GBP2024-06-30
2,746,792 GBP2023-06-30
Corporation Tax Payable
Current
472,869 GBP2023-06-30
Taxation/Social Security Payable
Current
868,698 GBP2024-06-30
601,477 GBP2023-06-30
Other Creditors
Current
24,959 GBP2024-06-30
21,353 GBP2023-06-30
Accrued Liabilities/Deferred Income
Current
751,352 GBP2024-06-30
1,895,515 GBP2023-06-30
Creditors
Current
6,161,982 GBP2024-06-30
6,446,446 GBP2023-06-30
Amounts owed to group undertakings
Non-current
6,751,061 GBP2024-06-30
Creditors
Non-current
6,751,061 GBP2024-06-30
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
-113,361 GBP2023-07-01 ~ 2024-06-30
Net Deferred Tax Liability/Asset
-113,361 GBP2024-06-30
Deferred Tax Liabilities
Accelerated tax depreciation
-113,361 GBP2024-06-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2 shares2024-06-30
2 shares2023-06-30
Par Value of Share
Class 1 ordinary share
12023-07-01 ~ 2024-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
37,000 GBP2024-06-30
37,000 GBP2023-06-30
Between one and five year
64,750 GBP2024-06-30
101,750 GBP2023-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
101,750 GBP2024-06-30
138,750 GBP2023-06-30
Related profiles found in government register
  • DEXCEL-PHARMA LIMITED
    Info
    Registered number 02963398
    icon of address7 Sopwith Way, Drayton Fields Industrial Estate, Daventry, Northamptonshire NN11 8PB
    PRIVATE LIMITED COMPANY incorporated on 1994-08-31 (31 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-23
    CIF 0
  • DEXCEL-PHARMA LIMITED
    S
    Registered number 02963398
    icon of address7, Sopwith Way, Drayton Fields Industrial Estate, Daventry, England, NN11 8PB
    Private Limited Company in Companies House, England
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • WHATDRUG LTD - 2016-01-27
    WHATDRUG.COM LIMITED - 2001-01-29
    icon of address7 Sopwith Way, Drayton Fields Industrial Estate, Daventry, Northants, England
    Dissolved Corporate (3 parents)
    Equity (Company account)
    Retained earnings (accumulated losses)
    -1,000 GBP2020-12-31
    Person with significant control
    icon of calendar 2016-04-06 ~ dissolved
    CIF 1 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.